Top Markets
#1 DogBull DogBull +68.40%
#2 Siren Siren +31.20%
#3 OriginTrail OriginTrail +20.67%
#4 MarsCoin MarsCoin +13.86%
#5 Verus Coin Verus Coin +7.38%
#6 PulseChain PulseChain +6.04%
#7 Xphere Xphere +6.03%
#8 Concordium Concordium +5.86%
#9 COTI COTI +5.07%
#10 NYC NYC +4.80%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
HST Global, Inc. HST Global, Inc.

HST Global, Inc.

HSTC
Clasificación en acciones #22246
HST Global, Inc. operates as a biotechnology firm dedicated to integrated... HST Global, Inc. operates as a biotechnology firm dedicated to integrated health and wellness. The company establishes and acquires a global network of specialized wellness centers, which offer homeopathic and alternative treatments primarily for patients suffering from advanced-stage cancers. Furthermore, HST Global focuses on the development of homeopathic and alternative therapeutic candidates that are either currently undergoing or have successfully completed clinical trials. These potential treatments are designed to address late-stage cancers as well as various other critical, life-threatening conditions. The company's corporate headquarters are situated in Hampton, Virginia.
Precio por acción
$0.65
Última sincronización: 2026-08-20
Capitalización bursátil
$91.93M
Cambio (1 día)
0.00%
Cambio (1 año)
324,900.01%
País
US
Comercio HST Global, Inc. (HSTC)

Categoría

Healthcare
Ganancias de HST Global, Inc. (HSTC)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di HST Global, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de HST Global, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH